Medpace Holdings, Inc.
MEDP US58506Q1094
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Burwig Susan E EX VP |
480.00 USD |
10,000 Sold |
4,800,000 USD |
03/09/2025 | 03/09/2025 |
| Troendle August J. CEO |
475.11 USD |
1,197 Sold |
568,707 USD |
29/08/2025 | 02/09/2025 |
| Troendle August J. CEO |
475.90 USD |
36,196 Sold |
17,225,676 USD |
29/08/2025 | 29/08/2025 |
| Troendle August J. CEO |
475.00 USD |
620 Sold |
294,500 USD |
27/08/2025 | 27/08/2025 |
| Troendle August J. CEO |
475.00 USD |
620 Sold |
294,500 USD |
27/08/2025 | 27/08/2025 |
| Mccarthy Cornelius P. Iii |
465.04 USD |
1,662 Sold |
772,896 USD |
19/08/2025 | 19/08/2025 |
| Troendle August J. CEO |
451.69 USD |
48,487 Sold |
21,901,093 USD |
28/07/2025 | 28/07/2025 |
| Burwig Susan E EX VP |
450.14 USD |
7,500 Sold |
3,376,050 USD |
28/07/2025 | 28/07/2025 |
| Ewald Stephen P SR OFF |
450.00 USD |
3,000 Sold |
1,350,000 USD |
28/07/2025 | 28/07/2025 |
| Geiger Jesse J PR |
453.11 USD |
41,801 Sold |
18,940,451 USD |
24/07/2025 | 24/07/2025 |